SCOPUS 정보 검색 플랫폼

PharmacoEconomics

Volumn 18, Issue 2, 2000, Pages 125-141

Clinical trials and the new good clinical practice guideline in Japan: An economic perspective

(2) Ono, S a Kodama, Y b

a NATIONAL INSTITUTE OF HEALTH SCIENCES (Japan)

b Org Pharmaceutical Safety and Res (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COST BENEFIT ANALYSIS; GOOD CLINICAL PRACTICE; HEALTH CARE SYSTEM; JAPAN; MEDICAL ETHICS; PATIENT INFORMATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW;

EID: 0033885455 PISSN: 11707690 EISSN: None Source Type: Journal
DOI: 10.2165/00019053-200018020-00003 Document Type: Review

Times cited : (18)

References (35)

1
- 0008416389
- International Conference on Harmonisation (ICH) Harmonised Tripartite Guideline (Step 4) Guideline for Good Clinical Practice. Geneva: ICH-secretariat
- (1996)

2
- 0008445337
- Central Pharmaceutical Affairs Council. CPAC Notification No. 40. Tokyo: Ministry of Health and Welfare
- (1997)

3
- 0008415621
- Pharmaceutical Affairs Bureau. PAB Notification No. 430, Tokyo: Ministry of Health and Welfare
- (1997)

4
- 0028537195
- Pharmaceutical prices, quantities and innovation
- (1994) Pharmacoeconomics , vol.6 , Issue.5 , pp. 425-433
- Ikegami, N.¹ Michell, W.² Penner-Hahn, P.³

5
- 0028784041
- Medical care in Japan
- (1995) N Engl J Med , vol.333 , pp. 1295-1299
- Ikegami, N.¹ Campbell, J.G.²

6
- 0008416390
- Japan's New G.C.P. and other Rules on Clinical Trials. (Pt 3) Tokyo: Yakuji Nippo
- (1999) , pp. 1-8
- Tominaga, T.¹

7
- 0008422688
- Ministry of Health and Welfare G.C.P. workshop (Fukuoka) Tokyo: Medical Information Express
- (1997)

8
- 0008460251
- Development of new drugs and clinical trials [in Japanese]. Tokyo: Lifescience Publications
- (1995)
- Nakano, S.¹

9
- 0008486862
- Pharmaceutical Affairs Bureau P.A.B. Notification No. 874. Tokyo: Ministry of Health and Welfare
- (1989)

10
- 0030803133
- Ethical complexities of conducting research in developing countries
- (1997) N Engl J Med , vol.337 , pp. 1003-1005
- Varmus, H.¹ Satcher, D.²

11
- 0000041584
- Definition of the quality of clinical trials
- (1998) Jpn J Clin Pharmacol Ther , vol.29 , Issue.3 , pp. 591-592
- Ono, S.¹

12
- 0000482966
- Current status of informed consent in Japanese clinical trials
- (1997) Jpn Pharmacol Ther , vol.25 , Issue.9 , pp. 2223-2247
- Nakano, S.¹

13
- 0008503823
- US Office of Inspector General. Department of Health and Human Services. Institution review boards: a time for reform. [on line] [accessed 2000 Jun 20]
- (1998)

14
- 0008506177
- Japanese Pharmaceutical Manufacturers Association Reports on Monitoring and Data Management in the US [in Japanese]. Rinsho-Iyaku
- (1998) , vol.13 , Issue.13 , pp. 3337-3357

15
- 0008503824
- For the uninsured, experiments may provide the only treatment. New York Times [on line]. [accessed 2000 Jun 28]
- (1999)
- Kolata, G.¹ Eigenwald, K.²

16
- 0008445339
- International Conference on Harmonisation (ICH) Harmonised Tripartite Guideline (Step 4). Statistical Principles for Clinical Trials. Geneva: ICH-secretariat
- (1998)

17
- 0008492240
- International Conference on Harmonisation (ICH) Harmonised Tripartite Guideline (Step 2). Choice of Control Group in Clinical Trials. Geneva: ICH-secretariat
- (1999)

18
- 0008418914
- Clinical decision analysis. Philadelphia (PA): Saunders
- (1980) , pp. 133-139
- Weinstein, M.C.¹ Fineberg, H.V.²

19
- 0008501469
- Statistical approach for drug evaluation-influence of International Harmonization
- (1997) Kokyu , vol.16 , Issue.6 , pp. 897-901
- Ohashi, Y.¹

20
- 17644444061
- Drug approval in Japan questioned
- (1998) Lancet , vol.352 , pp. 491
- Hayashi, K.¹ Hashimoto, K.² Yanagi, M.³

21
- 0000025155
- On the recent topics in the comparative clinical trials
- (1995) Clin Eval , vol.23 , Issue.3 , pp. 489-521
- Hirotsu, C.¹

22
- 0008467428
- US House of Representatives and Senate The Medicare Cancer Clinical Trial Coverage Act of 1999 [on line]
- (2000)

23
- 0008424295
- International Conference on Harmonisation (ICH) Harmonised Tripartite Guideline (step 4). Ethnic Factors in the Acceptability of Foreign Clinical Data. Geneva: ICH-secretariat
- (1998)

24
- 0008505339
- Cost-benefit analysis. Cambridge: Cambridge University Press
- (1994)
- Layard, R.¹ Glaister, S.²

25
- 0008482262
- PhRMA Pharmaceutical Industry Profile, [on line]. [Accessed 2000 Jun 20]
- (1999)

26
- 0032887408
- Current status of oral anticancer drugs in Japan
- (1999) J Clin Oncol , vol.17 , Issue.10 , pp. 3362-3365
- Fugiwara, Y.¹

27
- 0032040174
- Essential conditions for the development of new anticancer drugs based on ICH-GCP
- (1998) Jpn J Cancer Chemother , vol.25 , Issue.5 , pp. 671-684
- Saijyo, N.¹

28
- 0008482263
- Industry structure, strategy, and public policy. New York (NY): HarperCollins
- (1996)
- Scherer, F.M.¹

29
- 0008416391
- Cost-effectiveness in health and medicine. Chapter 21. Oxford: Oxford University Press
- (1996) , pp. 188-208
- Gold, M.R.¹ Siegel, J.E.² Russell, L.B.³

30
- 0008418915
- International Federation of Pharmaceutical Manufacturers Associations (IFPMA) The value and benefits of ICH to industry. Geneva: IFPMA
- (2000)

31
- 0008415622
- Ministry of Education. Survey on clinical trials conducted at national university and college hospitals [in Japanese]. Tokyo: Ministry of Education
- (1998)

32
- 0008445340
- Ministry of Education. Notification No. 11-20. Tokyo: Ministry of Education
- (1999)

33
- 0008423419
- A survey result
- (1998) Asahi Shimbun

34
- 0033565691
- What's the price of a research subject? Approaches to payment for research participation
- (1999) N Engl J Med , vol.341 , pp. 198-203
- Dickert, N.¹ Grady, C.²

35
- 0008482265
- Ministry of Health and Welfare Study on new GCP implementation (final report) [in Japanese]. Tokyo: Ministry of Health and Welfare
- (1998)

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.